1
|
Lanvin PL, Li D, Conrad S, Magot A, Micaelli X, Péréon Y, Vincent M, Isidor B, Sternberg D, McCormick EM, Hakonarson H, Mercier S, Falk MJ. Expanding the Spectrum of Congenital Myopathy Linked to Variants in the MYBPC1 Gene: A Clinical Report. Neurol Clin Pract 2024; 14:e200228. [PMID: 38690148 PMCID: PMC11057435 DOI: 10.1212/cpj.0000000000200228] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/11/2023] [Accepted: 11/07/2023] [Indexed: 05/02/2024]
Abstract
Objectives Heterozygous missense variants in MYBPC1 have been recently identified in 13 patients from 6 families with congenital myopathy with tremor. All the patients had mild skeletal myopathy invariably associated with a distinctive myogenic tremor and hypotonia with gradual clinical improvement. However, no phenotypic description has been reported for the neonatal respiratory impairment that patients may suffer. Methods We report 3 new patients from 2 independent families with congenital myopathy with tremor. Results Tremors and respiratory distress associated with stridor should raise the diagnosis of congenital myopathy with tremors linked to MYBPC1-dominant variants in children with neonatal hypotonia. Discussion Neonatal severe respiratory impairment requiring intensive noninvasive ventilation because of stridor is described in 2 patients. Stridor was previously reported in one other case and is part of the clinical features.
Collapse
Affiliation(s)
- Pierre-Louis Lanvin
- CHU Nantes (P-LL, SC, MV, BI, SM), Department of Medical Genetics, France; The Center for Applied Genomics (DL, HH); Division of Human Genetics (DL, HH); Department of Pediatrics (DL, HH, MJF), Perelman School of Medicine, Children's Hospital of Philadelphia, University of Pennsylvania, Philadelphia, PA; CHU Nantes (AM, YP), Department of Clinical Neurophysiology; Reference Centre for Neuromuscular Disorders AOC (AM, YP, SM), Filnemus, Euro-NMD, Nantes; CHD Vendée (XM), Service de Pédiatrie, La Roche sur Yon, France; Nantes Université (MV, BI, SM), CNRS, INSERM, l'institut du thorax; APHP (DS), Metabolic Biochemistry Department, Genetics Center, Pitié-Salpêtrière Hospital Group, Center of Research in Myology, APHP Sorbonne University, Paris, France; Mitochondrial Medicine Frontier Program (EMM, MJF), Division of Human Genetics, Department of Pediatrics; and Division of Pulmonary Medicine (HH), The Joseph Stokes, Jr. Research Institute, Children's Hospital of Philadelphia, PA
| | - Dong Li
- CHU Nantes (P-LL, SC, MV, BI, SM), Department of Medical Genetics, France; The Center for Applied Genomics (DL, HH); Division of Human Genetics (DL, HH); Department of Pediatrics (DL, HH, MJF), Perelman School of Medicine, Children's Hospital of Philadelphia, University of Pennsylvania, Philadelphia, PA; CHU Nantes (AM, YP), Department of Clinical Neurophysiology; Reference Centre for Neuromuscular Disorders AOC (AM, YP, SM), Filnemus, Euro-NMD, Nantes; CHD Vendée (XM), Service de Pédiatrie, La Roche sur Yon, France; Nantes Université (MV, BI, SM), CNRS, INSERM, l'institut du thorax; APHP (DS), Metabolic Biochemistry Department, Genetics Center, Pitié-Salpêtrière Hospital Group, Center of Research in Myology, APHP Sorbonne University, Paris, France; Mitochondrial Medicine Frontier Program (EMM, MJF), Division of Human Genetics, Department of Pediatrics; and Division of Pulmonary Medicine (HH), The Joseph Stokes, Jr. Research Institute, Children's Hospital of Philadelphia, PA
| | - Solène Conrad
- CHU Nantes (P-LL, SC, MV, BI, SM), Department of Medical Genetics, France; The Center for Applied Genomics (DL, HH); Division of Human Genetics (DL, HH); Department of Pediatrics (DL, HH, MJF), Perelman School of Medicine, Children's Hospital of Philadelphia, University of Pennsylvania, Philadelphia, PA; CHU Nantes (AM, YP), Department of Clinical Neurophysiology; Reference Centre for Neuromuscular Disorders AOC (AM, YP, SM), Filnemus, Euro-NMD, Nantes; CHD Vendée (XM), Service de Pédiatrie, La Roche sur Yon, France; Nantes Université (MV, BI, SM), CNRS, INSERM, l'institut du thorax; APHP (DS), Metabolic Biochemistry Department, Genetics Center, Pitié-Salpêtrière Hospital Group, Center of Research in Myology, APHP Sorbonne University, Paris, France; Mitochondrial Medicine Frontier Program (EMM, MJF), Division of Human Genetics, Department of Pediatrics; and Division of Pulmonary Medicine (HH), The Joseph Stokes, Jr. Research Institute, Children's Hospital of Philadelphia, PA
| | - Armelle Magot
- CHU Nantes (P-LL, SC, MV, BI, SM), Department of Medical Genetics, France; The Center for Applied Genomics (DL, HH); Division of Human Genetics (DL, HH); Department of Pediatrics (DL, HH, MJF), Perelman School of Medicine, Children's Hospital of Philadelphia, University of Pennsylvania, Philadelphia, PA; CHU Nantes (AM, YP), Department of Clinical Neurophysiology; Reference Centre for Neuromuscular Disorders AOC (AM, YP, SM), Filnemus, Euro-NMD, Nantes; CHD Vendée (XM), Service de Pédiatrie, La Roche sur Yon, France; Nantes Université (MV, BI, SM), CNRS, INSERM, l'institut du thorax; APHP (DS), Metabolic Biochemistry Department, Genetics Center, Pitié-Salpêtrière Hospital Group, Center of Research in Myology, APHP Sorbonne University, Paris, France; Mitochondrial Medicine Frontier Program (EMM, MJF), Division of Human Genetics, Department of Pediatrics; and Division of Pulmonary Medicine (HH), The Joseph Stokes, Jr. Research Institute, Children's Hospital of Philadelphia, PA
| | - Xavier Micaelli
- CHU Nantes (P-LL, SC, MV, BI, SM), Department of Medical Genetics, France; The Center for Applied Genomics (DL, HH); Division of Human Genetics (DL, HH); Department of Pediatrics (DL, HH, MJF), Perelman School of Medicine, Children's Hospital of Philadelphia, University of Pennsylvania, Philadelphia, PA; CHU Nantes (AM, YP), Department of Clinical Neurophysiology; Reference Centre for Neuromuscular Disorders AOC (AM, YP, SM), Filnemus, Euro-NMD, Nantes; CHD Vendée (XM), Service de Pédiatrie, La Roche sur Yon, France; Nantes Université (MV, BI, SM), CNRS, INSERM, l'institut du thorax; APHP (DS), Metabolic Biochemistry Department, Genetics Center, Pitié-Salpêtrière Hospital Group, Center of Research in Myology, APHP Sorbonne University, Paris, France; Mitochondrial Medicine Frontier Program (EMM, MJF), Division of Human Genetics, Department of Pediatrics; and Division of Pulmonary Medicine (HH), The Joseph Stokes, Jr. Research Institute, Children's Hospital of Philadelphia, PA
| | - Yann Péréon
- CHU Nantes (P-LL, SC, MV, BI, SM), Department of Medical Genetics, France; The Center for Applied Genomics (DL, HH); Division of Human Genetics (DL, HH); Department of Pediatrics (DL, HH, MJF), Perelman School of Medicine, Children's Hospital of Philadelphia, University of Pennsylvania, Philadelphia, PA; CHU Nantes (AM, YP), Department of Clinical Neurophysiology; Reference Centre for Neuromuscular Disorders AOC (AM, YP, SM), Filnemus, Euro-NMD, Nantes; CHD Vendée (XM), Service de Pédiatrie, La Roche sur Yon, France; Nantes Université (MV, BI, SM), CNRS, INSERM, l'institut du thorax; APHP (DS), Metabolic Biochemistry Department, Genetics Center, Pitié-Salpêtrière Hospital Group, Center of Research in Myology, APHP Sorbonne University, Paris, France; Mitochondrial Medicine Frontier Program (EMM, MJF), Division of Human Genetics, Department of Pediatrics; and Division of Pulmonary Medicine (HH), The Joseph Stokes, Jr. Research Institute, Children's Hospital of Philadelphia, PA
| | - Marie Vincent
- CHU Nantes (P-LL, SC, MV, BI, SM), Department of Medical Genetics, France; The Center for Applied Genomics (DL, HH); Division of Human Genetics (DL, HH); Department of Pediatrics (DL, HH, MJF), Perelman School of Medicine, Children's Hospital of Philadelphia, University of Pennsylvania, Philadelphia, PA; CHU Nantes (AM, YP), Department of Clinical Neurophysiology; Reference Centre for Neuromuscular Disorders AOC (AM, YP, SM), Filnemus, Euro-NMD, Nantes; CHD Vendée (XM), Service de Pédiatrie, La Roche sur Yon, France; Nantes Université (MV, BI, SM), CNRS, INSERM, l'institut du thorax; APHP (DS), Metabolic Biochemistry Department, Genetics Center, Pitié-Salpêtrière Hospital Group, Center of Research in Myology, APHP Sorbonne University, Paris, France; Mitochondrial Medicine Frontier Program (EMM, MJF), Division of Human Genetics, Department of Pediatrics; and Division of Pulmonary Medicine (HH), The Joseph Stokes, Jr. Research Institute, Children's Hospital of Philadelphia, PA
| | - Bertrand Isidor
- CHU Nantes (P-LL, SC, MV, BI, SM), Department of Medical Genetics, France; The Center for Applied Genomics (DL, HH); Division of Human Genetics (DL, HH); Department of Pediatrics (DL, HH, MJF), Perelman School of Medicine, Children's Hospital of Philadelphia, University of Pennsylvania, Philadelphia, PA; CHU Nantes (AM, YP), Department of Clinical Neurophysiology; Reference Centre for Neuromuscular Disorders AOC (AM, YP, SM), Filnemus, Euro-NMD, Nantes; CHD Vendée (XM), Service de Pédiatrie, La Roche sur Yon, France; Nantes Université (MV, BI, SM), CNRS, INSERM, l'institut du thorax; APHP (DS), Metabolic Biochemistry Department, Genetics Center, Pitié-Salpêtrière Hospital Group, Center of Research in Myology, APHP Sorbonne University, Paris, France; Mitochondrial Medicine Frontier Program (EMM, MJF), Division of Human Genetics, Department of Pediatrics; and Division of Pulmonary Medicine (HH), The Joseph Stokes, Jr. Research Institute, Children's Hospital of Philadelphia, PA
| | - Damien Sternberg
- CHU Nantes (P-LL, SC, MV, BI, SM), Department of Medical Genetics, France; The Center for Applied Genomics (DL, HH); Division of Human Genetics (DL, HH); Department of Pediatrics (DL, HH, MJF), Perelman School of Medicine, Children's Hospital of Philadelphia, University of Pennsylvania, Philadelphia, PA; CHU Nantes (AM, YP), Department of Clinical Neurophysiology; Reference Centre for Neuromuscular Disorders AOC (AM, YP, SM), Filnemus, Euro-NMD, Nantes; CHD Vendée (XM), Service de Pédiatrie, La Roche sur Yon, France; Nantes Université (MV, BI, SM), CNRS, INSERM, l'institut du thorax; APHP (DS), Metabolic Biochemistry Department, Genetics Center, Pitié-Salpêtrière Hospital Group, Center of Research in Myology, APHP Sorbonne University, Paris, France; Mitochondrial Medicine Frontier Program (EMM, MJF), Division of Human Genetics, Department of Pediatrics; and Division of Pulmonary Medicine (HH), The Joseph Stokes, Jr. Research Institute, Children's Hospital of Philadelphia, PA
| | - Elizabeth M McCormick
- CHU Nantes (P-LL, SC, MV, BI, SM), Department of Medical Genetics, France; The Center for Applied Genomics (DL, HH); Division of Human Genetics (DL, HH); Department of Pediatrics (DL, HH, MJF), Perelman School of Medicine, Children's Hospital of Philadelphia, University of Pennsylvania, Philadelphia, PA; CHU Nantes (AM, YP), Department of Clinical Neurophysiology; Reference Centre for Neuromuscular Disorders AOC (AM, YP, SM), Filnemus, Euro-NMD, Nantes; CHD Vendée (XM), Service de Pédiatrie, La Roche sur Yon, France; Nantes Université (MV, BI, SM), CNRS, INSERM, l'institut du thorax; APHP (DS), Metabolic Biochemistry Department, Genetics Center, Pitié-Salpêtrière Hospital Group, Center of Research in Myology, APHP Sorbonne University, Paris, France; Mitochondrial Medicine Frontier Program (EMM, MJF), Division of Human Genetics, Department of Pediatrics; and Division of Pulmonary Medicine (HH), The Joseph Stokes, Jr. Research Institute, Children's Hospital of Philadelphia, PA
| | - Hakon Hakonarson
- CHU Nantes (P-LL, SC, MV, BI, SM), Department of Medical Genetics, France; The Center for Applied Genomics (DL, HH); Division of Human Genetics (DL, HH); Department of Pediatrics (DL, HH, MJF), Perelman School of Medicine, Children's Hospital of Philadelphia, University of Pennsylvania, Philadelphia, PA; CHU Nantes (AM, YP), Department of Clinical Neurophysiology; Reference Centre for Neuromuscular Disorders AOC (AM, YP, SM), Filnemus, Euro-NMD, Nantes; CHD Vendée (XM), Service de Pédiatrie, La Roche sur Yon, France; Nantes Université (MV, BI, SM), CNRS, INSERM, l'institut du thorax; APHP (DS), Metabolic Biochemistry Department, Genetics Center, Pitié-Salpêtrière Hospital Group, Center of Research in Myology, APHP Sorbonne University, Paris, France; Mitochondrial Medicine Frontier Program (EMM, MJF), Division of Human Genetics, Department of Pediatrics; and Division of Pulmonary Medicine (HH), The Joseph Stokes, Jr. Research Institute, Children's Hospital of Philadelphia, PA
| | - Sandra Mercier
- CHU Nantes (P-LL, SC, MV, BI, SM), Department of Medical Genetics, France; The Center for Applied Genomics (DL, HH); Division of Human Genetics (DL, HH); Department of Pediatrics (DL, HH, MJF), Perelman School of Medicine, Children's Hospital of Philadelphia, University of Pennsylvania, Philadelphia, PA; CHU Nantes (AM, YP), Department of Clinical Neurophysiology; Reference Centre for Neuromuscular Disorders AOC (AM, YP, SM), Filnemus, Euro-NMD, Nantes; CHD Vendée (XM), Service de Pédiatrie, La Roche sur Yon, France; Nantes Université (MV, BI, SM), CNRS, INSERM, l'institut du thorax; APHP (DS), Metabolic Biochemistry Department, Genetics Center, Pitié-Salpêtrière Hospital Group, Center of Research in Myology, APHP Sorbonne University, Paris, France; Mitochondrial Medicine Frontier Program (EMM, MJF), Division of Human Genetics, Department of Pediatrics; and Division of Pulmonary Medicine (HH), The Joseph Stokes, Jr. Research Institute, Children's Hospital of Philadelphia, PA
| | - Marni J Falk
- CHU Nantes (P-LL, SC, MV, BI, SM), Department of Medical Genetics, France; The Center for Applied Genomics (DL, HH); Division of Human Genetics (DL, HH); Department of Pediatrics (DL, HH, MJF), Perelman School of Medicine, Children's Hospital of Philadelphia, University of Pennsylvania, Philadelphia, PA; CHU Nantes (AM, YP), Department of Clinical Neurophysiology; Reference Centre for Neuromuscular Disorders AOC (AM, YP, SM), Filnemus, Euro-NMD, Nantes; CHD Vendée (XM), Service de Pédiatrie, La Roche sur Yon, France; Nantes Université (MV, BI, SM), CNRS, INSERM, l'institut du thorax; APHP (DS), Metabolic Biochemistry Department, Genetics Center, Pitié-Salpêtrière Hospital Group, Center of Research in Myology, APHP Sorbonne University, Paris, France; Mitochondrial Medicine Frontier Program (EMM, MJF), Division of Human Genetics, Department of Pediatrics; and Division of Pulmonary Medicine (HH), The Joseph Stokes, Jr. Research Institute, Children's Hospital of Philadelphia, PA
| |
Collapse
|